Inhibrx Inc (INBX)
34.06
-0.03
(-0.09%)
USD |
NASDAQ |
Apr 26, 16:00
34.05
-0.01
(-0.03%)
After-Hours: 20:00
Inhibrx Cash from Investing (Quarterly): -3.442M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.442M |
| September 30, 2023 | -0.811M |
| June 30, 2023 | -0.317M |
| March 31, 2023 | -0.023M |
| December 31, 2022 | -0.267M |
| September 30, 2022 | 0.02M |
| June 30, 2022 | -0.322M |
| March 31, 2022 | -0.117M |
| December 31, 2021 | -0.267M |
| September 30, 2021 | -0.169M |
| June 30, 2021 | -0.359M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.014M |
| December 31, 2020 | -0.612M |
| September 30, 2020 | -0.299M |
| June 30, 2020 | -0.362M |
| March 31, 2020 | -0.091M |
| December 31, 2019 | -0.335M |
| September 30, 2019 | -0.711M |
| June 30, 2019 | -0.687M |
| March 31, 2019 | -0.077M |
| June 30, 2018 | -0.511M |
| March 31, 2018 | -0.075M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.442M
Minimum
Dec 2023
0.02M
Maximum
Sep 2022
-0.4834M
Average
-0.317M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Axonics Inc | -37.92M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -56.82M |
| Cash from Financing (Quarterly) | 0.86M |
| Free Cash Flow | -197.90M |
| Free Cash Flow Per Share (Quarterly) | -1.114 |
| Free Cash Flow to Equity (Quarterly) | -61.51M |
| Free Cash Flow to Firm (Quarterly) | -56.74M |
| Free Cash Flow Yield | -12.33% |